Linked Data API

Show Search Form

Search Results

76618
registered interest false more like this
date less than 2014-07-09more like thismore than 2014-07-09
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Neurofibromatosis more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government what plans they have to develop a national service framework for neurofibromatosis Type 1 sufferers. more like this
tabling member printed
Lord Hunt of Kings Heath more like this
uin HL960 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-07-14more like thismore than 2014-07-14
answer text <p>The number of people with neurofibromatosis type 1 (NF1) in England is estimated to number 11,267. The condition can be mild in some patients, manifesting itself only in patches of skin discolouration and soft benign bumps under the skin (neurofibromas), but for others NF1 causes more serious complications, including a rare form of cancer, curvature of the spine and nerve problems caused by more invasive neurofibromas.</p><p> </p><p>Since 1 April 2013, NHS England has been responsible for securing high quality care for all patients with complex NF1 as part of its specialised commissioning responsibilities. NHS England's NF1 service specification clearly sets out what needs to be in place for providers to offer evidence-based, safe and effective care, ensuring equity of access to a nationally consistent, high quality service. Specialist care is delivered by two designated centres based in Manchester (Central Manchester University Hospitals NHS Foundation Trust) and London (Guys and St. Thomas' NHS Foundation Trust, London) and these provide outreach support into other cities. The service is available to all patients with a suspected or confirmed diagnosis of NF1.</p><p> </p><p>The service specification can be viewed on the NHS England website at the following link:</p><p> </p><p>www.england.nhs.uk/wp-content/uploads/2013/06/b13-comp-neurofib-1.pdf.</p>
answering member printed Earl Howe remove filter
grouped question UIN
HL961 more like this
HL962 more like this
question first answered
less than 2014-07-14T16:18:37.8359721Zmore like thismore than 2014-07-14T16:18:37.8359721Z
answering member
2000
label Biography information for Earl Howe more like this
tabling member
2024
label Biography information for Lord Hunt of Kings Heath more like this
76619
registered interest false more like this
date less than 2014-07-09more like thismore than 2014-07-09
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Neurofibromatosis more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government how they will ensure a co-ordinated response at local level for neurofibromatosis Type 1 sufferers. more like this
tabling member printed
Lord Hunt of Kings Heath more like this
uin HL961 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-07-14more like thismore than 2014-07-14
answer text <p>The number of people with neurofibromatosis type 1 (NF1) in England is estimated to number 11,267. The condition can be mild in some patients, manifesting itself only in patches of skin discolouration and soft benign bumps under the skin (neurofibromas), but for others NF1 causes more serious complications, including a rare form of cancer, curvature of the spine and nerve problems caused by more invasive neurofibromas.</p><p> </p><p>Since 1 April 2013, NHS England has been responsible for securing high quality care for all patients with complex NF1 as part of its specialised commissioning responsibilities. NHS England's NF1 service specification clearly sets out what needs to be in place for providers to offer evidence-based, safe and effective care, ensuring equity of access to a nationally consistent, high quality service. Specialist care is delivered by two designated centres based in Manchester (Central Manchester University Hospitals NHS Foundation Trust) and London (Guys and St. Thomas' NHS Foundation Trust, London) and these provide outreach support into other cities. The service is available to all patients with a suspected or confirmed diagnosis of NF1.</p><p> </p><p>The service specification can be viewed on the NHS England website at the following link:</p><p> </p><p>www.england.nhs.uk/wp-content/uploads/2013/06/b13-comp-neurofib-1.pdf.</p>
answering member printed Earl Howe remove filter
grouped question UIN
HL960 more like this
HL962 more like this
question first answered
remove maximum value filtermore like thismore than 2014-07-14T16:18:38.4851111Z
answering member
2000
label Biography information for Earl Howe more like this
tabling member
2024
label Biography information for Lord Hunt of Kings Heath more like this
76608
registered interest false more like this
date less than 2014-07-08more like thismore than 2014-07-08
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Health Services and Social Services more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government what was the combined spending on health and social care in the financial year 2013–14. more like this
tabling member printed
Lord Stoddart of Swindon more like this
uin HL952 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-07-14more like thismore than 2014-07-14
answer text <p>Provisional spending outturn figures for all government departments will be published in HM Treasury's Public Expenditure Statistical Analyses on the 15 July.</p><p> </p><p>For the Department this will include a provisional total spending forecast against the Total Departmental Expenditure Limit control of £109,721 million.</p><p> </p><p>Final spending outturn figures will be published in the 2013-14 Department of Health Annual Report and Accounts, due to be laid to Parliament in July 2014.</p><p> </p> more like this
answering member printed Earl Howe remove filter
question first answered
less than 2014-07-14T12:58:52.9420911Zmore like thismore than 2014-07-14T12:58:52.9420911Z
answering member
2000
label Biography information for Earl Howe more like this
tabling member
950
label Biography information for Lord Stoddart of Swindon more like this
65841
registered interest false more like this
date less than 2014-07-03more like thismore than 2014-07-03
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Pharmaceutical Price Regulation Scheme more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government how much rebate they have so far received from pharmaceutical companies under the new Pharmaceutical Price Regulation Scheme agreement. more like this
tabling member printed
Lord Hunt of Kings Heath more like this
uin HL833 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-07-09more like thismore than 2014-07-09
answer text <p>The Department has received £74 million from members of the Pharmaceutical Price Regulation Scheme (PPRS) in respect of PPRS payments for the first quarter of the calendar year 2014. The Department intends to publish aggregate information on sales reports and payments made under the scheme on a quarterly basis. The first such publication was made on 30 June and can be found on the Government's website at:</p><p> </p><p>www.gov.uk/government/publications/pprs-quarterly-net-sales-and-payment-information</p><p> </p><p>In respect of England, the anticipated payments in 2014-15 have been passed on to NHS England through the Mandate and as such were included within commissioner allocations.</p><p> </p><p>The Government is committed to improving access to clinically and cost-effective medicines including innovative new medicines. As part of implementing the PPRS, NHS England and the Association of the British Pharmaceutical Industry are discussing how best to improve access to, and optimise patient outcomes from, these medicines.</p>
answering member printed Earl Howe remove filter
grouped question UIN
HL834 more like this
HL835 more like this
question first answered
less than 2014-07-09T15:18:03.7423231Zmore like thismore than 2014-07-09T15:18:03.7423231Z
answering member
2000
label Biography information for Earl Howe more like this
tabling member
2024
label Biography information for Lord Hunt of Kings Heath more like this
65842
registered interest false more like this
date less than 2014-07-03more like thismore than 2014-07-03
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Pharmaceutical Price Regulation Scheme more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government whether the rebate they receive from pharmaceutical companies under the new Pharmaceutical Price Regulation Scheme agreement will be reallocated as an additional resource to the National Health Service. more like this
tabling member printed
Lord Hunt of Kings Heath more like this
uin HL834 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-07-09more like thismore than 2014-07-09
answer text <p>The Department has received £74 million from members of the Pharmaceutical Price Regulation Scheme (PPRS) in respect of PPRS payments for the first quarter of the calendar year 2014. The Department intends to publish aggregate information on sales reports and payments made under the scheme on a quarterly basis. The first such publication was made on 30 June and can be found on the Government's website at:</p><p> </p><p>www.gov.uk/government/publications/pprs-quarterly-net-sales-and-payment-information</p><p> </p><p>In respect of England, the anticipated payments in 2014-15 have been passed on to NHS England through the Mandate and as such were included within commissioner allocations.</p><p> </p><p>The Government is committed to improving access to clinically and cost-effective medicines including innovative new medicines. As part of implementing the PPRS, NHS England and the Association of the British Pharmaceutical Industry are discussing how best to improve access to, and optimise patient outcomes from, these medicines.</p>
answering member printed Earl Howe remove filter
grouped question UIN
HL833 more like this
HL835 more like this
question first answered
less than 2014-07-09T15:18:04.494439Zmore like thismore than 2014-07-09T15:18:04.494439Z
answering member
2000
label Biography information for Earl Howe more like this
tabling member
2024
label Biography information for Lord Hunt of Kings Heath more like this
65843
registered interest false more like this
date less than 2014-07-03more like thismore than 2014-07-03
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Pharmaceutical Price Regulation Scheme more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government to what extent they propose to use the rebate they expect to receive from pharmaceutical companies under the new Pharmaceutical Price Regulation Scheme agreement to invest in innovative new medicines and procedures. more like this
tabling member printed
Lord Hunt of Kings Heath more like this
uin HL835 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-07-09more like thismore than 2014-07-09
answer text <p>The Department has received £74 million from members of the Pharmaceutical Price Regulation Scheme (PPRS) in respect of PPRS payments for the first quarter of the calendar year 2014. The Department intends to publish aggregate information on sales reports and payments made under the scheme on a quarterly basis. The first such publication was made on 30 June and can be found on the Government's website at:</p><p> </p><p>www.gov.uk/government/publications/pprs-quarterly-net-sales-and-payment-information</p><p> </p><p>In respect of England, the anticipated payments in 2014-15 have been passed on to NHS England through the Mandate and as such were included within commissioner allocations.</p><p> </p><p>The Government is committed to improving access to clinically and cost-effective medicines including innovative new medicines. As part of implementing the PPRS, NHS England and the Association of the British Pharmaceutical Industry are discussing how best to improve access to, and optimise patient outcomes from, these medicines.</p>
answering member printed Earl Howe remove filter
grouped question UIN
HL833 more like this
HL834 more like this
question first answered
less than 2014-07-09T15:18:04.5972691Zmore like thismore than 2014-07-09T15:18:04.5972691Z
answering member
2000
label Biography information for Earl Howe more like this
tabling member
2024
label Biography information for Lord Hunt of Kings Heath more like this
65846
registered interest false more like this
date less than 2014-07-03more like thismore than 2014-07-03
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Better Care Fund more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government what plans there are for each Health and Wellbeing Board to agree performance measures for implementing the Better Care Fund; and what progress has been made to date. more like this
tabling member printed
Lord Kennedy of Southwark more like this
uin HL838 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-07-14more like thismore than 2014-07-14
answer text <p>Following a review of the first set of local plans for the Better Care Fund (BCF), it has become clear that while the majority of areas have made good progress, there is more we need to do to ensure every area is on track to deliver from next April.</p><p> </p><p>As part of this, Ministers have agreed revised arrangements for the pay for performance scheme to ensure that financial benefits linked to reductions in emergency admissions can be clearly demonstrated and that health services and councils share the financial responsibility if emergency admissions are not reduced.</p><p> </p><p>Key elements of the agreement are:</p><p> </p><p>- BCF performance payments will now be linked to reducing emergency admissions;</p><p>- the size of the performance payment will be determined by local decisions on the level of ambition for the reduction in emergency admissions and the amount spent on local NHS services, as set out in the plan agreed by the local Health and Wellbeing Board;</p><p>- the remaining money from the performance pot not earned through reducing emergency admissions will be used to support local NHS services, as agreed by Health and Wellbeing Boards; and</p><p>- the wider metrics in the initial performance framework will continue to be used to monitor progress, but will not be used in assessments for the pay for performance scheme.</p><p> </p><p>Revised guidance on the new pay for performance scheme and further information required to improve BCF plans will be provided to the sector in coming weeks, alongside details of support available and the timetable for submitting revised plans.</p>
answering member printed Earl Howe remove filter
question first answered
less than 2014-07-14T16:17:46.6220921Zmore like thismore than 2014-07-14T16:17:46.6220921Z
answering member
2000
label Biography information for Earl Howe more like this
tabling member
4153
label Biography information for Lord Kennedy of Southwark more like this
65241
registered interest false more like this
date less than 2014-07-02more like thismore than 2014-07-02
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Folic Acid more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government whether the Department of Health expects soon to start discussions with the relevant food industry companies about their willingness in principle to stop voluntary fortification of food products with folic acid, if mandatory fortification were to be introduced; and, if so, when. more like this
tabling member printed
Lord Rooker more like this
uin HL771 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-07-14more like thismore than 2014-07-14
answer text <p>Discussions with relevant food industry companies have begun. The Department is in the process of contacting organisations across a range of sectors and we hope to complete these discussions by the end of 2014.</p><p> </p><p>The Department is in the final stages of commissioning research to explore any new and innovative communication approaches that would be effective in raising awareness among women of the need to take folic acid supplements and in promoting behaviour change. This research is scheduled for completion in the first quarter of 2015.</p> more like this
answering member printed Earl Howe remove filter
grouped question UIN HL772 more like this
question first answered
less than 2014-07-14T16:14:06.0397472Zmore like thismore than 2014-07-14T16:14:06.0397472Z
answering member
2000
label Biography information for Earl Howe more like this
tabling member
302
label Biography information for Lord Rooker more like this
65242
registered interest false more like this
date less than 2014-07-02more like thismore than 2014-07-02
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Folic Acid more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government whether the Department of Health have explored whether there are any new and innovative communication approaches that would be effective in raising awareness among women, particularly those in lower socio-economic groups who are at greater risk of a neural tube defect-affected pregnancy, of the case for taking folic acid supplements, and in promoting behaviour change. more like this
tabling member printed
Lord Rooker more like this
uin HL772 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-07-14more like thismore than 2014-07-14
answer text <p>Discussions with relevant food industry companies have begun. The Department is in the process of contacting organisations across a range of sectors and we hope to complete these discussions by the end of 2014.</p><p> </p><p>The Department is in the final stages of commissioning research to explore any new and innovative communication approaches that would be effective in raising awareness among women of the need to take folic acid supplements and in promoting behaviour change. This research is scheduled for completion in the first quarter of 2015.</p> more like this
answering member printed Earl Howe remove filter
grouped question UIN HL771 more like this
question first answered
less than 2014-07-14T16:14:07.4771787Zmore like thismore than 2014-07-14T16:14:07.4771787Z
answering member
2000
label Biography information for Earl Howe more like this
tabling member
302
label Biography information for Lord Rooker more like this
65251
registered interest false more like this
date less than 2014-07-02more like thismore than 2014-07-02
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Self-harm more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government how many (1) girls, and (2) boys, aged under 18 received hospital treatment for self-harm in each year since 2010. more like this
tabling member printed
Baroness Kennedy of Cradley more like this
uin HL781 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-07-14more like thismore than 2014-07-14
answer text <p>Data on the number of under 18 boys and girls who received hospital treatment for self-harm in each year since 2010 is in the following table.</p><p> </p><table><tbody><tr><td colspan="7"><p><strong> </strong></p><p>Count of finished admission episodeswith a cause code of self-harm and a count of accident and emergency attendances (excluding planned attendances) with a patient group of deliberate self-harm for (1) females under 18 and (2) males under 18 for 2010-11, 2011-12 and 2012-13.</p></td></tr><tr><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td colspan="6"><p>Activity in English NHS Hospitals and English NHS commissioned activity in the independent sector</p></td><td> </td></tr><tr><td rowspan="2"><p>Year</p></td><td colspan="2"><p>Accident and emergency attendances</p></td><td colspan="2"><p>Finished admission episodes</p></td><td> </td><td> </td></tr><tr><td><p>Male</p></td><td><p>Female</p></td><td><p>Male</p></td><td><p>Female</p></td><td> </td><td> </td></tr><tr><td><p>2010-11</p></td><td><p>4,038</p></td><td><p>9,264</p></td><td><p>2,594</p></td><td><p>11,400</p></td><td> </td><td> </td></tr><tr><td><p>2011-12</p></td><td><p>4,287</p></td><td><p>9,388</p></td><td><p>2,363</p></td><td><p>10,868</p></td><td> </td><td> </td></tr><tr><td><p>2012-13</p></td><td><p>3,800</p></td><td><p>9,943</p></td><td><p>2,473</p></td><td><p>12,305</p></td><td> </td><td> </td></tr><tr><td colspan="5"><p><em>Source:</em> Hospital Episode Statistics (HES), Health and Social Care Information Centre</p></td><td> </td><td> </td></tr></tbody></table><p> </p><p><em>Notes: </em></p><p> </p><p>- Admissions do not represent the number of inpatients as a person may have more than one admission in one year; and</p><p> </p><p>- a patient may have attended Accident and Emergency (A&amp;E) and then been admitted to hospital as a single event, in this case the event would be included in both the A&amp;E and hospital admission figures.</p><p> </p><p>Analysis of how these statistics compare with the rest of Europe has not been made.</p><p>Data is not collected on the incidence of self-harm among boys and girls aged under 18 nor those who continue to self-harm in adulthood.</p><p> </p>
answering member printed Earl Howe remove filter
grouped question UIN
HL783 more like this
HL785 more like this
question first answered
less than 2014-07-14T16:15:02.9476944Zmore like thismore than 2014-07-14T16:15:02.9476944Z
answering member
2000
label Biography information for Earl Howe more like this
tabling member
4303
label Biography information for Baroness Kennedy of Cradley more like this